Physician profile

James L Bruton

Nephrology (Internal Medicine) · Fort Smith, AR

NPI 1245228055

$4,943.36

in general payments reported to CMS, 2019-2025

32 companies · $1,339 in 2025

The $1,339 reported for 2025 was more than what 84% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,612.54
Education$28.51

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals Lp $578.15 2019-2025 Farxiga, Lokelma
Amgen INC. $547.92 2022-2025 Tavneos, Krystexxa, Parsabiv
Novartis Pharmaceuticals Corporation $356.50 2023-2025
Novo Nordisk INC $340.59 2019-2025 Rybelsus, Ozempic, Wegovy
Glaxosmithkline, LLC. $332.89 2021-2025 Benlysta
Opko Pharmaceuticals, LLC $320.58 2019-2024 Rayaldee
Horizon Therapeutics Plc $303.60 2019-2023 Krystexxa
Travere Therapeutics, INC. $287.66 2023-2025
Ardelyx, INC. $214.28 2024-2025 Ibsrela
Aurinia Pharma U.S., INC. $200.47 2022-2024 Lupkynis
Fresenius USA Marketing, INC. $171.82 2019-2024 Velphoro
Vifor Pharma, INC. $157.73 2019-2022
Bayer Healthcare Pharmaceuticals INC. $152.97 2023-2025
Boehringer Ingelheim Pharmaceuticals, INC. $134.42 2023-2025 Jardiance
Calliditas Therapeutics US INC. $122.69 2023-2025 Tarpeyo
Show all 32 companies
CompanyGeneral paymentsYearsTop products
Akebia Therapeutics INC $116.17 2019-2025 Vafseo
Ani Pharmaceuticals, INC. $104.15 2022-2025 Purified Cortrophin Gel
Otsuka America Pharmaceutical, INC. $81.52 2019-2024 Jynarque
Janssen Pharmaceuticals, INC $66.32 2024 Xarelto
Alexion Pharmaceuticals, INC. $54.19 2024 Ultomiris
Mallinckrodt Enterprises LLC $47.17 2019
Ultragenyx Pharmaceutical INC. $46.42 2023
Cormedix INC. $34.66 2024 Defencath
Vantive US Healthcare LLC $24.33 2025 Renal - Pd
Abbvie INC. $21.63 2021
Bard Peripheral Vascular, INC. $20.99 2022
Takeda Pharmaceuticals U.S.A., INC. $19.50 2023 Gattex
Otsuka Pharmaceutical Development & Commercialization, INC. $18.30 2019
Daiichi Sankyo INC. $17.77 2019
Ascendis Pharma Endocrinology INC $17.14 2025 Yorvipath
Nxstage Medical, INC. $16.29 2025
Scpharmaceuticals INC. $14.54 2025

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

James L Bruton

$4,943.36

in general payments reported 2019-2025

Years
2019-2025
Top company
Astrazeneca Pharmaceuticals Lp
Context
The $1,339 reported for 2025 was more than what 84% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).

https://glasscript.com/doctor/282947/james-l-bruton

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.